leadf
logo-loader
viewSilence Therapeutics PLC

Silence Therapeutics - Proactive One2One Investor Forum May 2019

David Solomon, chief executive of Silence Therapeutics PLC (LON:SLN), presents at the Proactive Investors One2One Investor Forum in London May 2019.

For more information visit www.silence-therapeutics.com

Quick facts: Silence Therapeutics PLC

Price: 463 GBX

AIM:SLN
Market: AIM
Market Cap: £383.49 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Silence Therapeutics PLC named herein, including the promotion by the Company of Silence Therapeutics PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE 100 retreats as UK employment tumbles

Headlines from the Proactive UK newsroom. The FTSE100 was on the back foot as the new job numbers highlighted how business is suffering due to the pandemic. The blue chip-index shed 60 to 6,232. People on UK payrolls fell by 649,000 between March and June, according to the government....

on 16/7/20

2 min read